🚀 VC round data is live in beta, check it out!
- Public Comps
- Optiscan Imaging
Optiscan Imaging Valuation Multiples
Discover revenue and EBITDA valuation multiples for Optiscan Imaging and similar public comparables like electroCore, Outset Medical, Pangaea Oncology, Optomed and more.
Optiscan Imaging Overview
About Optiscan Imaging
Optiscan Imaging Ltd is engaged in the development, manufacture, and commercialization of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications. Its technology offers real-time, 3D, in vivo imaging at the single-cell level, in a non-destructive manner that enables clinicians to make immediate informed decisions. Its products include InVivage, ViewnVivo, and Customisation. Its geographical segments include Australia, Germany, Norway, China, and the United States.
Founded
1997
HQ

Employees
33
Website
Financials (FY)
EV
$52M
Optiscan Imaging Financials
Optiscan Imaging reported last fiscal year revenue of $666K and negative EBITDA of ($4M).
In the same fiscal year, Optiscan Imaging generated $335K in gross profit, ($4M) in EBITDA losses, and had net loss of ($4M).
Optiscan Imaging P&L
In the most recent fiscal year, Optiscan Imaging reported revenue of $666K and EBITDA of ($4M).
Optiscan Imaging expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $666K | XXX | XXX | XXX |
| Gross Profit | — | XXX | $335K | XXX | XXX | XXX |
| Gross Margin | — | XXX | 50% | XXX | XXX | XXX |
| EBITDA | — | XXX | ($4M) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (613%) | XXX | XXX | XXX |
| EBIT Margin | — | XXX | (985%) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($4M) | XXX | XXX | XXX |
| Net Margin | — | XXX | (663%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Optiscan Imaging Stock Performance
Optiscan Imaging has current market cap of $64M, and enterprise value of $52M.
Market Cap Evolution
Optiscan Imaging's stock price is $0.06.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $52M | $64M | 0.0% | XXX | XXX | XXX | $-0.00 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialOptiscan Imaging Valuation Multiples
Optiscan Imaging trades at 78.4x EV/Revenue multiple, and (12.8x) EV/EBITDA.
Optiscan Imaging Financial Valuation Multiples
As of March 17, 2026, Optiscan Imaging has market cap of $64M and EV of $52M.
Equity research analysts estimate Optiscan Imaging's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Optiscan Imaging has a P/E ratio of (14.4x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $64M | XXX | $64M | XXX | XXX | XXX |
| EV (current) | $52M | XXX | $52M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 78.4x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (12.8x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (8.0x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 155.5x | XXX | XXX | XXX |
| P/E | — | XXX | (14.4x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (11.8x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Optiscan Imaging Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Optiscan Imaging Margins & Growth Rates
Optiscan Imaging's revenue in the last fiscal year declined by (10%).
Optiscan Imaging Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | (10%) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (613%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 3% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 455% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 535% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 1035% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Optiscan Imaging Public Comps
See public comps and valuation multiples for other Medical Devices and Test & Measurement comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| electroCore | XXX | XXX | XXX | XXX | XXX | XXX |
| Outset Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Pangaea Oncology | XXX | XXX | XXX | XXX | XXX | XXX |
| Optomed | XXX | XXX | XXX | XXX | XXX | XXX |
| FluoGuide | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Optiscan Imaging M&A Activity
Optiscan Imaging acquired XXX companies to date.
Last acquisition by Optiscan Imaging was on XXXXXXXX, XXXXX. Optiscan Imaging acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Optiscan Imaging
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialOptiscan Imaging Investment Activity
Optiscan Imaging invested in XXX companies to date.
Optiscan Imaging made its latest investment on XXXXXXXX, XXXXX. Optiscan Imaging invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Optiscan Imaging
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Optiscan Imaging
| When was Optiscan Imaging founded? | Optiscan Imaging was founded in 1997. |
| Where is Optiscan Imaging headquartered? | Optiscan Imaging is headquartered in Australia. |
| How many employees does Optiscan Imaging have? | As of today, Optiscan Imaging has over 33 employees. |
| Is Optiscan Imaging publicly listed? | Yes, Optiscan Imaging is a public company listed on Australian Securities Exchange. |
| What is the stock symbol of Optiscan Imaging? | Optiscan Imaging trades under OIL ticker. |
| When did Optiscan Imaging go public? | Optiscan Imaging went public in 1997. |
| Who are competitors of Optiscan Imaging? | Optiscan Imaging main competitors are electroCore, Outset Medical, Pangaea Oncology, Optomed. |
| What is the current market cap of Optiscan Imaging? | Optiscan Imaging's current market cap is $64M. |
| What is the current revenue of Optiscan Imaging? | Optiscan Imaging's last fiscal year revenue is $666K. |
| What is the current EV/Revenue multiple of Optiscan Imaging? | Current revenue multiple of Optiscan Imaging is 78.4x. |
| Is Optiscan Imaging profitable? | No, Optiscan Imaging is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.